Posted in | News | Nanomedicine | Nanomaterials

Applied Nanoscience to Assist EFP in Response to FDA Comments

Applied Nanoscience Inc., a nanotechnology-based filtration development company, today announced that it has committed to fully assist its future merger partner Emergency Filtration Products, Inc. (EFP), the developer of the NanoMask™, in the response to comments issued by the U.S. Food and Drug Administration (FDA) in relation to the 510(k) pre-market notification filed by EFP in connection with the NanoMask.

"We have been working diligently to help EFP prepare the response to FDA comments regarding the NanoMask pre-market notification, especially as it relates to the antimicrobial silver nanoparticle formulation which powers the NanoMask," said Thomas K. Allen, President and CEO, ANI. "Applied Nanoscience's management and scientific team plan to rapidly provide EFP with the necessary data to satisfy the FDA comments."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Applied Nanoscience Inc.. (2019, March 19). Applied Nanoscience to Assist EFP in Response to FDA Comments. AZoNano. Retrieved on December 01, 2022 from https://www.azonano.com/news.aspx?newsID=7732.

  • MLA

    Applied Nanoscience Inc.. "Applied Nanoscience to Assist EFP in Response to FDA Comments". AZoNano. 01 December 2022. <https://www.azonano.com/news.aspx?newsID=7732>.

  • Chicago

    Applied Nanoscience Inc.. "Applied Nanoscience to Assist EFP in Response to FDA Comments". AZoNano. https://www.azonano.com/news.aspx?newsID=7732. (accessed December 01, 2022).

  • Harvard

    Applied Nanoscience Inc.. 2019. Applied Nanoscience to Assist EFP in Response to FDA Comments. AZoNano, viewed 01 December 2022, https://www.azonano.com/news.aspx?newsID=7732.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit